|  Help  |  About  |  Contact Us

Publication : IER3IP1 is critical for maintaining glucose homeostasis through regulating the endoplasmic reticulum function and survival of β cells.

First Author  Yang J Year  2022
Journal  Proc Natl Acad Sci U S A Volume  119
Issue  45 Pages  e2204443119
PubMed ID  36322741 Mgi Jnum  J:336782
Mgi Id  MGI:7435088 Doi  10.1073/pnas.2204443119
Citation  Yang J, et al. (2022) IER3IP1 is critical for maintaining glucose homeostasis through regulating the endoplasmic reticulum function and survival of beta cells. Proc Natl Acad Sci U S A 119(45):e2204443119
abstractText  Recessive mutations in IER3IP1 (immediate early response 3 interacting protein 1) cause a syndrome of microcephaly, epilepsy, and permanent neonatal diabetes (MEDS). IER3IP1 encodes an endoplasmic reticulum (ER) membrane protein, which is crucial for brain development; however, the role of IER3IP1 in beta cells remains unknown. We have generated two mouse models with either constitutive or inducible IER3IP1 deletion in beta cells, named IER3IP1-betaKO and IER3IP1-ibetaKO, respectively. We found that IER3IP1-betaKO causes severe early-onset, insulin-deficient diabetes. Functional studies revealed a markedly dilated beta-cell ER along with increased proinsulin misfolding and elevated expression of the ER chaperones, including PDI, ERO1, BiP, and P58IPK. Islet transcriptome analysis confirmed by qRT-PCR revealed decreased expression of genes associated with beta-cell maturation, cell cycle, and antiapoptotic genes, accompanied by increased expression of antiproliferation genes. Indeed, multiple independent approaches further demonstrated that IER3IP1-betaKO impaired beta-cell maturation and proliferation, along with increased condensation of beta-cell nuclear chromatin. Inducible beta-cell IER3IP1 deletion in adult (8-wk-old) mice induced a similar diabetic phenotype, suggesting that IER3IP1 is also critical for function and survival even after beta-cell early development. Importantly, IER3IP1 was decreased in beta cells of patients with type 2 diabetes (T2D), suggesting an association of IER3IP1 deficiency with beta-cell dysfunction in the more-common form of diabetes. These data not only uncover a critical role of IER3IP1 in beta cells but also provide insight into molecular basis of diabetes caused by IER3IP1 mutations.
Quick Links:
 
Quick Links:
 

Expression

Publication --> Expression annotations

 

Other

9 Bio Entities

0 Expression